The study, which included 183 breast cancer patients and 122 healthy individuals,
demonstrated effectiveness with an AUC of 0.832
,
as verified by the Ministry of Food and Drug Safety in South Korea.
MASTOCHECK quantitatively measures three breast cancer-related protein biomarkers in blood using LC-MS/MS (liquid chromatography–tandem mass spectrometry). The measured values are then analyzed using a proprietary algorithm to generate a comprehensive diagnostic result. By evaluating the combined expression patterns of these three biomarkers, MASTOCHECK enables high-accuracy detection of breast cancer.
If the test result indicates a high-risk classification, it is strongly recommended to consult a medical specialist and proceed with appropriate further confirmatory diagnostic procedures.
This product is a medical device. Please read and follow the precautions and instructions for use carefully.
The test results using this product alone cannot determine the diagnosis and treatment methods for stages 0, 1, and 2 of breast cancer.
For the diagnosis of stage 3 and 4 of breast cancer, additional clinical diagnostic tests are required.
